M1 Linear Ubiquitination of LKB1 Inhibits Vascular Endothelial Cell Injury in Atherosclerosis Through Activation of AMPK

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2023 Aug 26

PMID 37632629

Authors

Haiquan Huangfu

Zhichao Huang

Weiqian Liao

Tianyu Zou

Xiaoming Shang

Hairui Yu

Affiliations

Soon will be listed here.

Abstract

Endothelial cell injury is confirmed to be the initial step in the atherosclerosis (AS) process. Here, we tried to elucidate the role of liver kinase B1 (LKB1) and adenosine phosphate protein kinase (AMPK) in modulating vascular endothelial cells (VECs) in AS. High-fat feed (HFD)-induced AS rat models were prepared and treated with AMPK activator A-769662 alone or combined with chloroquine. An analysis of VEC injury, inflammation response, and autophagy followed it. The M1 linear ubiquitination of LKB1 was assessed by co-immunoprecipitation. The interaction between LKB1 and AMPK was analyzed. Primary aortic VECs were isolated and induced by LPS to verify the effects of LKB1 and AMPK on VEC injury in AS. Activation of AMPK reduced the VEC injury and inflammatory response of VECs and promoted autophagy caused by AS. LKB1 could regulate the activation of AMPK in AS. M1 linear ubiquitination enhanced LKB1 activity and increased AMPK activation to protect against VEC injury in AS, which was validated by in vitro experiments. Our current study highlighted that M1 linear ubiquitination of LKB1 may induce the activation of LKB1 to activate AMPK, which inhibited VEC injury in AS.

References

Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S . Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res. 2016; 118(4):535-46. DOI: 10.1161/CIRCRESAHA.115.307611. View

Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H . Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014; 5(8):927-46. PMC: 4258672. View

Gordts P, Esko J . Corrigendum to "The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis" [Matrix Biol. 71-72 (2018) 262-282]. Matrix Biol. 2020; 88:89. DOI: 10.1016/j.matbio.2020.02.002. View

Raggi P, Genest J, Giles J, Rayner K, Dwivedi G, Beanlands R . Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 2018; 276:98-108. DOI: 10.1016/j.atherosclerosis.2018.07.014. View

Weber C, Noels H . Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011; 17(11):1410-22. DOI: 10.1038/nm.2538. View

Lou X, Wang D, Gu Z, Li T, Ren L . Mechanism of microRNA regulating the progress of atherosclerosis in apoE-deficient mice. Bioengineered. 2021; 12(2):10994-11006. PMC: 8809940. DOI: 10.1080/21655979.2021.2004979. View

Wang S, Li J, Chen A, Song H . Differentiated expression of long non-coding RNA-small nucleolar RNA host gene 8 in atherosclerosis and its molecular mechanism. Bioengineered. 2021; 12(1):7167-7176. PMC: 8806704. DOI: 10.1080/21655979.2021.1979441. View

Chang X, Lochner A, Wang H, Wang S, Zhu H, Ren J . Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control. Theranostics. 2021; 11(14):6766-6785. PMC: 8171103. DOI: 10.7150/thno.60143. View

Wang J, Toan S, Zhou H . New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis. 2020; 23(3):299-314. DOI: 10.1007/s10456-020-09720-2. View

10.

Li L, Chen Y, Shi C . Nintedanib ameliorates oxidized low-density lipoprotein -induced inflammation and cellular senescence in vascular endothelial cells. Bioengineered. 2022; 13(3):6196-6207. PMC: 8974161. DOI: 10.1080/21655979.2022.2036913. View

11.

Yang Q, Xu J, Ma Q, Liu Z, Sudhahar V, Cao Y . PRKAA1/AMPKα1-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis. Nat Commun. 2018; 9(1):4667. PMC: 6220207. DOI: 10.1038/s41467-018-07132-x. View

12.

Luo Y, Lu S, Ai Q, Zhou P, Qin M, Sun G . SIRT1/AMPK and Akt/eNOS signaling pathways are involved in endothelial protection of total aralosides of Aralia elata (Miq) Seem against high-fat diet-induced atherosclerosis in ApoE-/- mice. Phytother Res. 2019; 33(3):768-778. DOI: 10.1002/ptr.6269. View

13.

Ou H, Liu C, Feng W, Xiao X, Tang S, Mo Z . Role of AMPK in atherosclerosis via autophagy regulation. Sci China Life Sci. 2018; 61(10):1212-1221. DOI: 10.1007/s11427-017-9240-2. View

14.

Akhshi T, Trimble W . A non-canonical Hedgehog pathway initiates ciliogenesis and autophagy. J Cell Biol. 2020; 220(1). PMC: 7714386. DOI: 10.1083/jcb.202004179. View

15.

Zhao R, Xu Z . Targeting the LKB1 tumor suppressor. Curr Drug Targets. 2014; 15(1):32-52. PMC: 3899349. DOI: 10.2174/1389450114666140106095811. View

16.

Liu Z, Zhu H, Dai X, Wang C, Ding Y, Song P . Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis. Circ Res. 2017; 121(9):1047-1057. PMC: 5640502. DOI: 10.1161/CIRCRESAHA.117.311546. View

17.

Tao H, Yancey P, Blakemore J, Zhang Y, Ding L, Jerome W . Macrophage SR-BI modulates autophagy via VPS34 complex and PPARα transcription of Tfeb in atherosclerosis. J Clin Invest. 2021; 131(7). PMC: 8011903. DOI: 10.1172/JCI94229. View

18.

Li G, Lin X, Zhang H, Li S, He X, Zhang K . Ox-Lp(a) transiently induces HUVEC autophagy via an ROS-dependent PAPR-1-LKB1-AMPK-mTOR pathway. Atherosclerosis. 2015; 243(1):223-35. DOI: 10.1016/j.atherosclerosis.2015.09.020. View

19.

Hasanvand A, Amini-Khoei H, Hadian M, Abdollahi A, Tavangar S, Dehpour A . Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy. Inflammopharmacology. 2016; 24(5):207-219. DOI: 10.1007/s10787-016-0275-2. View

20.

Rymut S, Lu B, Perez A, Corey D, Lamb K, Cotton C . Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2019; 316(6):L1081-L1093. PMC: 6620671. DOI: 10.1152/ajplung.00369.2018. View